Objective
Our objective is to determine whether this medication is safe and effective in people with type 1 diabetes.
Background Rationale
Currently there are no non-injectable therapies available to help improve glucose control in people with type 1 diabetes. This study will evaluate a novel oral medication that may help improve glucose control in people with type 1 diabetes.
Description of Project
Currently there are no non-injectable therapies available to help improve glucose control in people with type 1 diabetes. In this study, we will test a novel oral insulin-sensitizing medication to determine whether it can improve glucose control and reduce insulin doses in people with type 1 diabetes.
Anticipated Outcome
We anticipate that this medication will improve glucose control and reduce insulin doses in people with type 1 diabetes who utilize closed-loop automated insulin delivery. If our study is successful, we will then test it in a larger group of people with type 1 diabetes.
Relevance to T1D
If our study is successful, we will identify a new medication that may serve as an adjunct therapy to insulin in people with type 1 diabetes.